Y-mAbs Therapeutics
YMAB
YMAB
100 hedge funds and large institutions have $303M invested in Y-mAbs Therapeutics in 2022 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 32 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
100
Holders Change
+9
Holders Change %
+9.89%
% of All Funds
1.73%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
29
Reduced
32
Closed
7
Calls
$1.78M
Puts
–
Net Calls
+$1.78M
Net Calls Change
-$802K
Top Buyers
Top Sellers
| 1 |
1
AllianceBernstein
Nashville,
Tennessee
|
$31M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$19.9M |
| 3 |
3
Morgan Stanley
New York
|
$3.68M |
| 4 |
4
Invesco
Atlanta,
Georgia
|
$242K |
| 5 |
5
Dimensional Fund Advisors
Austin,
Texas
|
$1.91M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
HF
101
HRT Financial
New York
| – | -$479K | -31,678 | Closed |
|
|
E
102
Ergoteles
New York
| – | -$434K | -28,697 | Closed |
|
103
Balyasny Asset Management
Chicago,
Illinois
| – | -$214K | -14,122 | Closed |
|
104
DnB Asset Management
Oslo,
Norway
| – | -$203K | -13,399 | Closed |
|
105
Lazard Asset Management
New York
| – | -$85K | -5,655 | Closed |
|
106
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$2K | -154 | Closed |
|